China Shineway Pharmaceutical Group Ltd 的关键财务报表是什么?
CSWYY 的关键财务比率是什么?
China Shineway Pharmaceutical Group Ltd 的收入按细分市场或地理位置如何划分?
China Shineway Pharmaceutical Group Ltd 是否盈利?
China Shineway Pharmaceutical Group Ltd 有负债吗?
China Shineway Pharmaceutical Group Ltd 的流通股有多少?
关键数据
前收盘价
$19.25
开盘价
$22.08
当日区间
$19.25 - $22.54
52周范围
$18.53 - $22.54
交易量
1
平均成交量
0
每股收益(TTM)
3.09
股息收益率
--
市值
$15.9B
什么是 CSWYY?
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.